Clin2
NCT06537921Possibly a fitRecruiting

Testing minocycline for depression with obesity

ObesityMajor Depressive DisorderInflammation

Treatments studied

Part of Hormones & metabolism, Mental health clinical trials.

This trial tests whether adding the antibiotic minocycline to your current antidepressant helps people with both depression and obesity. It aims to see if reducing inflammation can improve mood.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
35 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must have depression that hasn't improved after trying at least two different antidepressants.
  • You must be currently taking an antidepressant and able to continue it during the study.
  • You must be willing to undergo two MRI brain scans.
  • Your blood test must show a certain level of inflammation (CRP >3 mg/L).
  • You cannot have active suicidal thoughts, bipolar disorder, psychosis, OCD, or PTSD.
  • You cannot have certain health conditions like autoimmune disorders, severe heart problems, or be pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06699966Not yet recruiting· Phase 4
Anti-inflammatory trial for depression

This study tests whether two anti-inflammatory drugs, celecoxib and minocycline, can help treat depression. You may join if you have moderate to severe depression and are not at high risk for certain medical conditions or drug interactions.

NCT05644301Recruiting· Phase 3
Blood-marker guided add-on treatment for major depression

This study tests whether doctors can choose the best add-on immune-related treatment for people with major depressive disorder by using inflammation blood tests. It’s meant for people whose depression has not improved enough with their current antidepressant.

Duffel, Antwerpen
NCT06450704Recruiting
Exercise for depression: brain and body health

This trial tests if a 12-week exercise program can reduce inflammation and improve brain function in people with depression. It's for adults currently taking antidepressant medication and looking for extra help through physical activity.

Alcalá de Henares, Madrid
NCT07493317Recruiting· Phase 2
Tocilizumab for depression with inflammation

This trial tests a medication called tocilizumab, which targets inflammation, to see if it can improve symptoms of major depression in people with signs of inflammation. You may be eligible if you have depression with a high monocyte count and significant loss of interest or pleasure.

New York, New York
NCT04751331Recruiting· Phase 1/Phase 2
Study brain response to inflammation in depression

This early-stage study tests how your brain responds to an “inflammatory challenge” in people with major depressive disorder and in healthy volunteers. It may help researchers understand the immune-to-brain link in depression and guide future treatments.

Tulsa, Oklahoma
NCT06110897Recruiting
Resistance Exercise for Depression Trial

This study tests whether resistance exercise (like lifting weights) can help reduce depression symptoms. If you have major depression and are not already doing regular resistance training, you may be able to join.

Ames, Iowa

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.